| Literature DB >> 23915640 |
Dana J Brimmer1, Elizabeth Maloney, Rebecca Devlin, James F Jones, Roumiana Boneva, Caryn Nagler, Lisa LeRoy, Scott Royal, Hao Tian, Jin-Mann S Lin, Jennifer Kasten, Elizabeth R Unger.
Abstract
BACKGROUND: Chronic fatigue syndrome (CFS) has no diagnostic clinical signs or biomarkers, so diagnosis requires ruling out conditions with similar signs and symptoms. We conducted a pilot registry of unexplained fatiguing illnesses and CFS to determine the feasibility of establishing and operating a registry and implementing an education outreach initiative. The pilot registry was conducted in Bibb County, Georgia. Patient referrals were obtained from healthcare providers who were identified by using various education outreach initiatives. These referrals were later supplemented with self-referrals by members of a local CFS support group. All patients meeting referral criteria were invited to participate in a screening interview to determine eligibility. If patients met registry criteria, they were invited to a one-day clinic for physical and laboratory evaluations. We classified patients based on the 1994 case definition.Entities:
Mesh:
Year: 2013 PMID: 23915640 PMCID: PMC3750716 DOI: 10.1186/1756-0500-6-309
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Registry referral inclusion and exclusion criteria
| To be eligible for referral to the registry, an individual must have met the following criteria: | Providers were instructed to rule out other potential causes of fatigue by conducting laboratory tests and medical history or medical histories alone before referring their patients. The registry had the following exclusion criteria: |
| • Unexplained severe fatigue persisting for one month or longer. | |
| • One of the following for at least one month: | |
| | • Pregnancy within past 12 months |
| | • Stroke with no full recovery |
| | • Parkinson’s disease |
| • A body mass index of less than 40.0 | • Chronic obstructive pulmonary disease (COPD) or congestive heart failure |
| • Age 12 to 59 (However, in November 2009, CDC expanded the eligible age range to 69 years of age. This upper age range limit was clarified to mean that in order to be eligible, the subject must be no more than 69 years of age as of the date of the most recent CDC IRB approval, September 2009). | |
| • Insulin-dependent diabetes | |
| • Uncontrolled diabetes type II (HgbA1c < 9%) | |
| • Anemia | |
| • Uncontrolled hypo- or hyper-thyroidism | |
| • Uncontrolled hypertension (BP > 140/90) | |
| • Sickle cell anemia | |
| • Cancer within 5 years (except basal skin) or current chemotherapy | |
| • Untreated depression | |
| • Substance abuse problems within the past 2 years | |
| • Anorexia nervosa or bulimia nervosa within the past 5 years | |
| • Schizophrenia, bipolar I or II disorder, or dementia | |
| • Hepatitis B or C |
*The registry inclusion/exclusion referral criteria are not for CFS classification.
Provider recruitment by type of provider (physician vs. non-physician)
| | ||||||
|---|---|---|---|---|---|---|
| 491 (59) | 147 (81) | 59 (59) | 373 (83) | 99 (16) | 1169 (57) | |
| 336 (41) | 33 (18) | 41 (41) | 75 (17) | 532 (84) | 1017 (46) | |
| 0 | 1 (<1) | 0 | 1 (<1) | 2 (<1) | 4 (<1) | |
| 827 | 181 | 100 | 449 | 633 | 2190 |
aOther/Unidentified refers to providers for whom the specialty is not known, with the exception of the “other” Ineligible, who was an office manager.
Referrals for clinical evaluation
| 58 (56) | 4b (50) | 4 (80) | 12c (86) | 78 (60) | |
| 46a (44) | 4d (50) | 1 (20) | 2e (14) | 53 (40) | |
| 104 | 8 | 5 | 14 | 131 |
aOne patient signed an informed consent form agreeing to share data from the GA First Follow-up Study with the GA Registry.
bNon-contact (n = 1); moved out of area (n = 1); unlocatable (n = 2).
cIneligible baseline registry subject (n = 1); ineligible based on age (n = 2); duplicate -- referred by 2 providers (n = 1); duplicate - referred under two different names (married and unmarried) (n = 1); Bipolar disorder reported during CATI interview (n = 2); BMI > 40 (n = 3); Rheumatoid arthritis reported during CATI interview (n = 1); BMI > 40 and emphysema reported during CATI interview (n = 1).
dAppointment canceled, had “too much going on” (n = 1), not feeling well enough to participate (n = 2); unlocatable (n = 1).
eBMI > 40.
Impact of education and outreach activities on referrals and clinic evaluation
| Focus group | 2 (5) | 10 (11) | 5 (9) |
| CMEa | 3 (7) | 4 (5) | 3 (5) |
| Meet and greet | 3 (7) | 7 (8) | 3 (5) |
| Incentive visit | 4 (10) | 12 (14) | 6 (10) |
| Visit only | 13 (31) | 31 (35) | 20 (34) |
| Two activities | 1 (2) | 1 (1) | 1 (2) |
| No contact | 16 (38) | 23 (26) | 20 (34) |
| 42 | 88 | 58 |
aContinuing medical education.
1Note: 36 (5%) of the 785 enrolled providers who did not make any referrals participated in the focus group, 66 (8%) had incentive visit, 73 (9%) had visit only, and 22 (3%) attended Meet and Greet (data on CME not available).
Demographics of clinical sample by illness classification
| | ||||
|---|---|---|---|---|
| | | | | |
| Female | 33 (89) | 13 (72) | 47 (96) | 93 (89) |
| Male | 4 (11) | 5 (28) | 2 (4) | 11 (11) |
| | | | | |
| Adolescent (<18) | 1 (3) | 3 (16) | 1 (2) | 5 (5) |
| 18-20 | 0 | 0 | 3 (6) | 3 (3) |
| 21-30 | 3 (8) | 3 (16) | 2 (4) | 8 (8) |
| 31-40 | 9 (24) | 3 (16) | 5 (11) | 17 (16) |
| 41-50 | 6 (16) | 1 (6) | 8 (16) | 15 (14) |
| 51-60 | 12 (32) | 6 (33) | 19 (39) | 37 (36) |
| 61-70 | 6 (16) | 2 (11) | 11 (22) | 19 (18) |
| | | | | |
| White | 33 (89) | 18 (100) | 40 (82) | 91 (88) |
| Black | 3 (8) | 0 | 7 (14) | 10 (10) |
| Other | 1 (3) | 0 | 2 (4) | 3 (3) |
| | | | | |
| 1st through 8th grade | 0 | 2 (11) | 0 | 2 (2) |
| Some high school | 3 (8) | 2 (11) | 5 (10) | 10 (10) |
| High school graduate | 5 (13) | 1 (6) | 8 (16) | 14 (13) |
| Trade/Technical/Vocational after | | | | |
| High School | 3 (8) | 0 | 9 (18) | 12 (12) |
| Some college | 6 (16) | 3 (17) | 13 (27) | 22 (21) |
| Two-year college graduate | 6 (16) | 4 (22) | 5 (10) | 15 (14) |
| Four-year college graduate | 6 (16) | 4 (22) | 2 (4) | 12 (12) |
| Postgraduate | 6 (16) | 2 (11) | 5 (10) | 13 (12) |
| Other | 2 (5) | 0 | 2 (4) | 4 (4) |
| | | | | |
| ≤18 | 2 (5) | 2 (11) | 0 | 4 (4) |
| 19-24 | 12 (32) | 5 (26) | 15 (31) | 32 (31) |
| 25-30 | 16 (43) | 7 (58) | 21 (43) | 44 (42) |
| 31-39 | 8 (22) | 4 (21) | 13 (27) | 25 (24) |
| | | | | |
| Yes | 20 (54) | 10 (56) | 27 (56) | 57 (55) |
| No | 16 (43) | 5 (28) | 21 (44) | 42 (40) |
| 37 | 18 | 49 | 104 |
aExcludes adolescent patients (n = 5).
Exclusion conditions at clinical evaluation
| Active inflammation | 1 | 1 |
| Alcohol abuse | 4 | – |
| Anemia | 2 | 1 |
| Anorexia bulimia | – | 1 |
| Autoimmune disorder | 1 | – |
| Bipolar | – | 2 |
| Cervical, thoracic, lumber spine disease | – | 1 |
| Diabetes Type II/insulin resistance | 7 | 1 |
| Hepatitis C | 1 | – |
| High blood urea | 2 | – |
| High C-reactive protein (CRP)a,b | 5 | 5 |
| Hypertension | 1 | – |
| Hypothyroidism | 7 | 3 |
| Major depressive disorder with melancholy | 2 | 2 |
| Mitochrondrial myopathy | – | 1 |
| Obesity | 2 | – |
| Obstructive sleep apnea | 1 | 1 |
| Osteoarthritis | 2 | – |
| Narcolepsy | 1 | – |
| Restless leg syndrome | 2 | 1 |
| Rheumatoid arthritis | 1 | – |
| Sleep problems | 1 | – |
| Schizophrenia | 1 | – |
| Sickle cell | – | 1 |
| Substance abuse | – | 3 |
| Uncontrolled high blood pressure | 1 | – |
| Urinary tract infection | 2 | 2 |
aPerson could have more than one exclusion condition and the exclusion could be based on one or multiple conditions.
bAll persons with high CRP were excluded for other coexisting medical conditions. While a high CRP value is not an exclusion as defined in the 1994 case definition, we identified persons with CRP values that were several fold higher than the upper limits of normal values, as there may be an underlying inflammatory, infectious, or cardiovascular disease.
Illness classification by referral and previous CFS diagnosis n (%)
| | | | | |
| Provider | 24 (65) | 14 (78) | 20 (41) | 9.21* |
| Support group | 13 (35) | 4 (22) | 29 (59) | |
| | | | | |
| Yes | 20 (56) | 10 (67) | 27 (56) | 7.25 |
| No | 16 (44) | 5 (33) | 21 (44) |
*p < 0.05.
aExcludes adolescent patients (n = 5).